BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 17618038)

  • 1. The role of contrast-enhanced ultrasound for focal liver lesion detection: an overview.
    Konopke R; Bunk A; Kersting S
    Ultrasound Med Biol; 2007 Oct; 33(10):1515-26. PubMed ID: 17618038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
    Hohmann J; Skrok J; Puls R; Albrecht T
    Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced ultrasonography in patients with colorectal liver metastases after chemotherapy.
    Konopke R; Bunk A; Kersting S
    Ultraschall Med; 2008 Sep; 29 Suppl 4():S203-9. PubMed ID: 18833498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New real-time image fusion technique for characterization of tumor vascularisation and tumor perfusion of liver tumors with contrast-enhanced ultrasound, spiral CT or MRI: first results.
    Jung EM; Schreyer AG; Schacherer D; Menzel C; Farkas S; Loss M; Feuerbach S; Zorger N; Fellner C
    Clin Hemorheol Microcirc; 2009; 43(1-2):57-69. PubMed ID: 19713601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid focal liver lesions indeterminate by contrast-enhanced CT or MR imaging: the added diagnostic value of contrast-enhanced ultrasound.
    Quaia E
    Abdom Imaging; 2012 Aug; 37(4):580-90. PubMed ID: 21894508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of treatment response after chemoembolisation (TACE) in hepatocellular carcinoma using real time image fusion of contrast-enhanced ultrasound (CEUS) and computed tomography (CT)--preliminary results.
    Wobser H; Wiest R; Salzberger B; Wohlgemuth WA; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2014; 57(2):191-201. PubMed ID: 24577382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of contrast enhanced ultrasonography in detection of liver metastases from colorectal cancer: a prospective double-blinded study.
    Larsen LP; Rosenkilde M; Christensen H; Bang N; Bolvig L; Christiansen T; Laurberg S
    Eur J Radiol; 2007 May; 62(2):302-7. PubMed ID: 17194561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of diagnostic performance of unenhanced vs SonoVue - enhanced ultrasonography in focal liver lesions characterization. The experience of three Italian centers.
    Quaia E; Stacul F; Gaiani S; Ricci P; Passariello R; Curzio D; Pozzi Mucelli R
    Radiol Med; 2004; 108(1-2):71-81. PubMed ID: 15269691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China.
    Lu MD; Yu XL; Li AH; Jiang TA; Chen MH; Zhao BZ; Zhou XD; Wang JR
    Ultrasound Med Biol; 2007 Nov; 33(11):1736-49. PubMed ID: 17629608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Contrast-enhanced ultrasound with Optison in percutaneous thermoablation of liver tumors].
    Jung EM; Clevert DA; Rupp N
    Rofo; 2003 Oct; 175(10):1403-12. PubMed ID: 14556110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of hepatic metastases with low MI real time contrast enhanced sonography and SonoVue.
    Oldenburg A; Hohmann J; Foert E; Skrok J; Hoffmann CW; Frericks B; Wolf KJ; Albrecht T
    Ultraschall Med; 2005 Aug; 26(4):277-84. PubMed ID: 16123921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhanced sonography in the characterization of small hepatocellular carcinomas in cirrhotic patients: comparison with contrast-enhanced ultrafast magnetic resonance imaging.
    Giorgio A; De Stefano G; Coppola C; Ferraioli G; Esposito V; Di Sarno A; Giorgio V; De Stefano M; Sangiovanni V; Liorre G; Del Viscovo L
    Anticancer Res; 2007; 27(6C):4263-9. PubMed ID: 18214030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
    Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M
    Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and characterisation of liver metastases.
    Albrecht T; Hohmann J; Oldenburg A; Skrok J; Wolf KJ
    Eur Radiol; 2004 Oct; 14 Suppl 8():P25-33. PubMed ID: 15700330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contrast enhanced ultrasound of the liver--state of the art].
    Dietrich CF; Schreiber-Dietrich D; Schuessler G; Ignee A
    Dtsch Med Wochenschr; 2007 Jun; 132(22):1225-31. PubMed ID: 17520509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.
    Seitz K; Strobel D; Bernatik T; Blank W; Friedrich-Rust M; Herbay Av; Dietrich CF; Strunk H; Kratzer W; Schuler A
    Ultraschall Med; 2009 Aug; 30(4):383-9. PubMed ID: 19688670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of contrast-enhanced sonography for the characterization of focal hepatic lesions in patients with diffuse liver disease: receiver operating characteristic analysis.
    Kim SH; Lee JM; Lee JY; Han JK; An SK; Han CJ; Lee KH; Hwang SS; Choi BI
    AJR Am J Roentgenol; 2005 Apr; 184(4):1077-84. PubMed ID: 15788576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of contrast-enhanced sonography of focal liver lesions before percutaneous biopsy.
    Wu W; Chen MH; Yin SS; Yan K; Fan ZH; Yang W; Dai Y; Huo L; Li JY
    AJR Am J Roentgenol; 2006 Sep; 187(3):752-61. PubMed ID: 16928941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of contrast-enhanced ultrasound in focal lesions of the liver using cadence contrast pulse sequencing.
    Bleuzen A; Huang C; Olar M; Tchuenbou J; Tranquart F
    Ultraschall Med; 2006 Feb; 27(1):40-8. PubMed ID: 16470478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
    Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
    Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.